5-year survival and other long-term outcomes from KEYNOTE-006 study of pembrolizumab (pembro) for ipilimumab (ipi)-naive advanced melanoma

Caroline Robert; Jacob Schachter; Georgina V. Long; Ana Arance; Jean-Jacques Grob; Laurent Mortier; Adil Daud; Matteo S. Carlino; Catriona McNeil; Michal Lotem; James Larkin; Paul Lorigan; Bart Neyns; Christian U. Blank; Omid Hamid; Teresa M. Petrella; James Anderson; Clemens Krepler; Scott J. Diede; Antoni Ribas

doi:10.1158/1538-7445.AM2019-CT188

5-year survival and other long-term outcomes from KEYNOTE-006 study of pembrolizumab (pembro) for ipilimumab (ipi)-naive advanced melanoma

Caroline Robert
, Jacob Schachter
, Georgina V. Long
, Ana Arance
, Jean-Jacques Grob
, Laurent Mortier
, Adil Daud
, Matteo S. Carlino
, Catriona McNeil
, Michal Lotem
, James Larkin
, Paul Lorigan
, Bart Neyns
, Christian U. Blank
, Omid Hamid
, Teresa M. Petrella
, James Anderson
, Clemens Krepler
, Scott J. Diede
, Antoni Ribas

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Journal	Cancer Research
Volume	79
Issue number	13
DOIs	https://doi.org/10.1158/1538-7445.AM2019-CT188
Publication status	Published - Jul 2019

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/1538-7445.AM2019-CT188

Cite this

Robert, C., Schachter, J., Long, G. V., Arance, A., Grob, J.-J., Mortier, L., Daud, A., Carlino, M. S., McNeil, C., Lotem, M., Larkin, J., Lorigan, P., Neyns, B., Blank, C. U., Hamid, O., Petrella, T. M., Anderson, J., Krepler, C., Diede, S. J., & Ribas, A. (2019). 5-year survival and other long-term outcomes from KEYNOTE-006 study of pembrolizumab (pembro) for ipilimumab (ipi)-naive advanced melanoma. Cancer Research, 79(13). https://doi.org/10.1158/1538-7445.AM2019-CT188

@article{22757d30b84f4e0c8839fd50efad708f,

title = "5-year survival and other long-term outcomes from KEYNOTE-006 study of pembrolizumab (pembro) for ipilimumab (ipi)-naive advanced melanoma",

author = "Caroline Robert and Jacob Schachter and Long, \{Georgina V.\} and Ana Arance and Jean-Jacques Grob and Laurent Mortier and Adil Daud and Carlino, \{Matteo S.\} and Catriona McNeil and Michal Lotem and James Larkin and Paul Lorigan and Bart Neyns and Blank, \{Christian U.\} and Omid Hamid and Petrella, \{Teresa M.\} and James Anderson and Clemens Krepler and Diede, \{Scott J.\} and Antoni Ribas",

year = "2019",

month = jul,

doi = "10.1158/1538-7445.AM2019-CT188",

language = "English",

volume = "79",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research",

number = "13",

}

Robert, C, Schachter, J, Long, GV, Arance, A, Grob, J-J, Mortier, L, Daud, A, Carlino, MS, McNeil, C, Lotem, M, Larkin, J, Lorigan, P, Neyns, B, Blank, CU, Hamid, O, Petrella, TM, Anderson, J, Krepler, C, Diede, SJ & Ribas, A 2019, '5-year survival and other long-term outcomes from KEYNOTE-006 study of pembrolizumab (pembro) for ipilimumab (ipi)-naive advanced melanoma', Cancer Research, vol. 79, no. 13. https://doi.org/10.1158/1538-7445.AM2019-CT188

TY - JOUR

T1 - 5-year survival and other long-term outcomes from KEYNOTE-006 study of pembrolizumab (pembro) for ipilimumab (ipi)-naive advanced melanoma

AU - Robert, Caroline

AU - Schachter, Jacob

AU - Long, Georgina V.

AU - Arance, Ana

AU - Grob, Jean-Jacques

AU - Mortier, Laurent

AU - Daud, Adil

AU - Carlino, Matteo S.

AU - McNeil, Catriona

AU - Lotem, Michal

AU - Larkin, James

AU - Lorigan, Paul

AU - Neyns, Bart

AU - Blank, Christian U.

AU - Hamid, Omid

AU - Petrella, Teresa M.

AU - Anderson, James

AU - Krepler, Clemens

AU - Diede, Scott J.

AU - Ribas, Antoni

PY - 2019/7

Y1 - 2019/7

U2 - 10.1158/1538-7445.AM2019-CT188

DO - 10.1158/1538-7445.AM2019-CT188

M3 - Meeting Abstract

SN - 0008-5472

VL - 79

JO - Cancer Research

JF - Cancer Research

IS - 13

ER -